Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.

MLA

Myszka, Aleksander, et al. “Irrelevance of CHEK2 Variants to Diagnosis of Breast/Ovarian Cancer Predisposition in Polish Cohort.” Journal of Applied Genetics, vol. 52, no. 2, May 2011, pp. 185–91. EBSCOhost, https://doi.org/10.1007/s13353-010-0013-1.

APA

Myszka, A., Karpinski, P., Slezak, R., Czemarmazowicz, H., Stembalska, A., Gil, J., Laczmanska, I., Bednarczyk, D., Szmida, E., & Sasiadek, M. M. (2011). Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort. Journal of Applied Genetics, 52(2), 185–191. https://doi.org/10.1007/s13353-010-0013-1

Chicago

Myszka, Aleksander, Pawel Karpinski, Ryszard Slezak, Halina Czemarmazowicz, Agnieszka Stembalska, Justyna Gil, Izabela Laczmanska, Damian Bednarczyk, Elzbieta Szmida, and Maria Malgorzata Sasiadek. 2011. “Irrelevance of CHEK2 Variants to Diagnosis of Breast/Ovarian Cancer Predisposition in Polish Cohort.” Journal of Applied Genetics 52 (2): 185–91. doi:10.1007/s13353-010-0013-1.